Draft:In Vivo (journal)

  • Comment: Could be notable, but we need to see evidence. DoubleGrazing (talk) 12:54, 13 March 2024 (UTC)

In Vivo, International Journal of Experimental and Clinical Pathophysiology and Drug Research
DisciplineOncology
LanguageEnglish
Edited byGeorge J. Delinasios
Publication details
History1987–present
Publisher
International Institute of Anticancer Research (Greece)
FrequencyBi-monthly
2.406 (2021)
Standard abbreviations
ISO 4Anticancer Res.
Indexing
ISSN0258-851X (print)
1791-7549 (web)
OCLC no.18319328
Links

In Vivo is an independent international peer-reviewed medical journal published by the International Institute of Anticancer Research, addressing experimental and clinical topics in oncology. Issues are released bi-monthly online (by Highwire Press), and an annual Index is also published. In Vivo was established in 1987 by John G. Delinassios.

According to the Journal Citation Reports, the journal had a 2021 impact factor of 2.406 and 5,776 total cites. The 2023 rejection rate was 65%.

According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category with an H-Index of 68.

Abstracting and indexing edit

Articles in In Vivo are abstracted and/or indexed by:

External links edit

Category:Oncology journals Category:Academic journals established in 1987 Category:English-language journals Category:Bi-monthly journals


References edit